Coeptis Therapeutics Secures Exclusive Rights to Negotiate to Acquire Transformational Cell Therapy Platform to Enable Potent Combinatorial Immuno-Oncology Treatment Strategies

/PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy...

Related Keywords

Sweden ,Stockholm ,Florida ,United States ,Tampa ,Dave Mehalick ,Arnika Wagner ,Karolinska Institutet ,Evren Alici ,Arnika Kathleen Wagner ,Jon Nugent ,Hans Gustaf Ljunggren ,Competence Center ,Vycellix Inc ,Prnewswire Coeptis Therapeutics Holdings Inc ,Exchange Commission ,H Lee Moffitt Cancer Center ,Nobel Assembly ,Nasdaq ,Securities Exchange ,Holdings Inc ,Coeptis Therapeutics Holdings Inc ,Coeptis Pharmaceuticals Inc ,Coeptis Therapeutics Inc ,Vygen Bio Inc ,Drug Administration ,University Of Pittsburgh ,Therapeutics Holdings ,Coepti Scientific Advisory ,Nobel Prize ,Coeptis Therapeutics Holdings ,Coeptis Therapeutics ,Coeptis Pharmaceuticals ,Moffitt Cancer Center ,Securities Act ,Securities Exchange Act ,Nasdaq Global Market ,